Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-24-219592
Filing Date
2024-09-16
Accepted
2024-09-16 16:05:57
Documents
3
Group Members
DAVID KROINDEEP TRACK BIOTECHNOLOGY MASTER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D d888084dsc13d.htm SC 13D 69931
2 EX-99.1 d888084dex991.htm EX-99.1 6140
3 EX-99.2 d888084dex992.htm EX-99.2 16105
  Complete submission text file 0001193125-24-219592.txt   93861
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-80035 | Film No.: 241301079
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 2034090812
Deep Track Capital, LP (Filed by) CIK: 0001856083 (see all company filings)

EIN.: 853360885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D